510(k) K222067
K222067 is an FDA 510(k) premarket notification submitted by Quanta Dialysis Technologies, Ltd. for the device "SC+ Hemodialysis Device, SC+ Dialysate Cartridge, SC+ Blood Tube Set". The FDA issued a decision of Substantially Equivalent on November 10, 2022. The device falls under product code KDI (Dialyzer, High Permeability With Or Without Sealed Dialysate System), a Class II device regulated under 21 CFR 876.5860. Quanta Dialysis Technologies, Ltd. has at least 3 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- November 10, 2022
- Date Received
- July 13, 2022
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Dialyzer, High Permeability With Or Without Sealed Dialysate System
- Device Class
- Class II
- Regulation Number
- 876.5860
- Review Panel
- GU
- Submission Type